WEDGE CAPITAL MANAGEMENT L L P/NC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1015308 CHARLOTTE, NC

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$3,599,846

-$281,475 QoQ

Shares Held

69,643

-10.8% QoQ

Ownership

0.120%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 34.2216733914392.ToString("F0")% Shared 0.ToString("F0")% None 65.7783266085608.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WEDGE CAPITAL MANAGEMENT L L P/NC holds $76,652,917 across 8 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	54,673	$32,419,995
2	VTRS	Viatris Inc	1,944,173	$26,265,777
3	ALKS	Alkermes plc.	151,234	$5,347,634
4	SUPN	Supernus Pharmaceuticals, Inc. This page	69,643	$3,599,846
5	PBH	Prestige Consumer Healthcare Inc.	54,034	$3,202,595
6	COLL	Collegium Pharmaceutical, Inc	71,353	$2,359,643
7	IRWD	Ironwood Pharmaceuticals Inc	540,492	$1,897,126
8	ANIP	Ani Pharmaceuticals Inc	20,290	$1,560,301

All Filings in SUPN

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,599,846	69,643	-10.8%	Shares	Sole	2026-04-13
2025-12-31	$3,881,321	78,095	+12.2%	Shares	Sole	2026-01-14
2025-09-30	$3,325,275	69,581	-5.8%	Shares	Sole	2025-10-10
2025-06-30	$2,329,328	73,900	+9.8%	Shares	Sole	2025-07-11
2025-03-31	$2,203,616	67,286	+26.2%	Shares	Sole	2025-04-14
2024-12-31	$1,928,448	53,331	—	Shares	Sole	2025-01-15
No filing history on record for this holder in this stock.